Glimepiride treatment and IGF-I in adolescents with type 1 diabetes: A prospective, randomized, double-blind, placebo-controlled study [1]

Diabetes Care

Volumn 26, Issue 4, 2003, Pages 1312-1313

  Wudy, Stefan A ^a,c   Hogel, Josef ^a   Dollinger, Barbara ^b   Mullis, Primus ^b   Heinze, Eberhard ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLIBENCLAMIDE; GLIMEPIRIDE; HEMOGLOBIN A1C; INSULIN; PLACEBO; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SULFONYLUREA DERIVATIVE;

ADOLESCENT; BLOOD PRESSURE; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DOUBLE BLIND PROCEDURE; DRUG SAFETY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LETTER; PROSPECTIVE STUDY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT OUTCOME; VIRUS ENCEPHALITIS;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; PLACEBOS; SULFONYLUREA COMPOUNDS;

EID: 0042167387     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.4.1312     Document Type: Letter

References (6)

1. Acerini C-L, Patton CM, Savage MO, Kernell A, Westphal O, Dunger DB: Randomised placebo-controlled trial of human recombinant insulin-like growth factor I plus intensive insulin therapy in adolescents with insulin-dependent diabetes mellitus. Lancet 350:1199-1204, 1997
2. Panten U, Schwanstecher M, Schwanstecher C: Mode of action of sulfonylureas. In Handbook of Experimental pharmacology, Vol 119, Oral Antidiabetics. Kuhlmann J, Puls W, Eds. Berlin, Heidelberg, New York, Springer, 1996, p. 129-159
3. Heinze E, Ranke M, Manske E, Vetter U, Voigt KH: The effect of glibenclamide on plasma insulin, serum somatomedin bioactivity and skeletal growth in hypophysectomized rats. Acta Endocrinologica 101: 187-192, 1982
4. Heinze E, Vetter U, Holl RW, Brenner E: Glibenclamide stimulates growth of human chondrocytes by IGF I dependent mechanisms. Exp Clin Endocrinol 103: 260-265, 1995
5. Mullis PE, Hofer G, Eblèe A, Kuhlmann B, Heinze E: Sulfonylureas have a positive and dose dependent effect on IGF-I transcription and production in a human hepatoma cell line (Abstract). Horm Res 50 (Suppl. 3):94, 1998
6. Clemmons DR, Moses AC, McKay MJ, Sommer A, Rosen DM, Ruckle J: The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity. J Clin Endocrinol Metab 85:1518-1524, 2000